Premier Alternatives

NeoChord

Maple Grove, MN · Founded 2007 · Privately Held (backing)

Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function. NeoChord is based in Maple Grove, MN and was founded in 2007. Its last reported valuation was $50 million in Jun 2015. It has raised $95.4 million across 13 recorded rounds; the latest was a $493,240 seed round in Feb 2025.

Last reported valuation
$50.0M
Oct 2026
Priced at
—
Total raised
$95.4M
Last round
Seed Round
Feb 2025

NeoChord key facts

as of Oct 2026
  • Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function.
  • NeoChord is valued at approximately $50.0M as of Oct 2026 (last reported valuation).
  • It has raised $95.4M across 13 recorded rounds; the latest was Seed Round ($493K) in Feb 2025.
  • Notable investors include Deerfield Management, Mayo Clinic Ventures, Baird Capital, Andcor Companies, CHV Capital — 18 tracked in total.
  • NeoChord has filed 21 Form Ds with the SEC since 2009, most recently Mar 2025 ($493K sold to 14 investors).
  • Status: Privately Held (backing).
Last reported valuation
LOW confidence
$50.0M

NeoChord's last reported valuation, Jun 2015. Nothing priced has surfaced since.

set by last reported valuationas of Oct 2026question about this number?
Free account
More of NeoChord with a free account
  • ·The complete investor list: 18 names
  • ·Watch NeoChord: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

NeoChord funding rounds

13 rounds
Feb 2025Seed Round$493KSEC filing▮
Aug 2024Seed Round$914KSEC filing▮
Jun 2023Seed Round$4.6MSEC filing▮
Sep 2022Seed Round$2.9MSEC filing▮
Feb 2022Seed Round$1.8MSEC filing▮
Full funding history →

NeoChord valuation

NeoChord's last reported valuation was $50 million in Jun 2015. No priced round, secondary trade or fund mark has surfaced since.

How much has NeoChord raised?

NeoChord has raised $95.4 million across 13 recorded rounds since 2012. The largest was a $914,291 seed round in Aug 2024; the most recent was a $493,240 seed round in Feb 2025.

NeoChord has filed 21 Form Ds with the SEC since 2009, most recently in Mar 2025 ($493,240 sold to 14 investors).

NeoChord investors

18 investors are on record for NeoChord, including Deerfield Management, Mayo Clinic Ventures, Baird Capital and Andcor Companies. The seed round in Feb 2025 drew 14 investors.

About NeoChord

Developer of an artificial chordae delivery system designed to resolve and restore normal mitral valve function. The company's system is used for conducting a minimally invasive procedure when the native chordae tendinae have become elongated or ruptured, while the heart is beating and bypasses the need for conducting cardiopulmonary bypass or aortic cross-clamping, enabling surgeons to stop the leakage of blood backward through the mitral valve in patients suffering from mitral regurgitation.

Sector
Healthcare
HQ
Maple Grove, MN, United States
Founded
2007
Employees
18
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.